Aperio Technologies
Vista, California, United States
About Aperio Technologies
Aperio is the leading provider of digital pathology solutions in hospitals, reference labs, and pharmaceutical and research institutions across the world. Today, our affordable and complete product portfolio improves patient care by enhancing quality assurance, delivering more efficient workflows, facilitating access to new and more targeted therapies, and improving pathologists' skills via lifelong education. Our comprehensive product line features our ScanScope® scanners, Spectrum™ image management (PACS) software, SecondSlide® slide sharing service for pathology, and image analysis tools and services. Aperio's products are FDA cleared for specific clinical applications, and are intended for research and education use for other applications.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $61.6M
- Funding stage: M&A
- Last round: Debt Financing (Aug 2012)
- Website: aperio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Hospital, Medical Device, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/aperio-technologies-2475182 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.